Piramal Pharma shares hit 5% lower circuit after listing
Earlier last week, the company obtained a go-ahead from the National Company Law Tribunal (NCLT) for the listing of its equity shares. Furthermore, the listing of the stock is well in line with the companys plan to list it by the third quarter of the current fiscal year.